Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial
Resource Type
Article
Authors
Davies, Michael A ; Saiag, Philippe ; Robert, Caroline ; Grob, Jean-Jacques ; Flaherty, Keith T ; Arance, Ana ; Chiarion-Sileni, Vanna ; Thomas, Luc ; Lesimple, Thierry ; Mortier, Laurent ; Moschos, Stergios J ; Hogg, David ; Márquez-Rodas, Iván ; Del Vecchio, Michele ; Lebbé, Céleste ; Meyer, Nicolas ; Zhang, Ying ; Huang, Yingjie ; Mookerjee, Bijoyesh ; Long, Georgina V
Source
In The Lancet Oncology July 2017 18(7):863-873
Subject
Primary Research Articles
Language
ISSN
1470-2045